Home » Lab News
Category Archives: Lab News
• Dr. Göktuna has attended The Outstanding Young Scientist Award Ceremony in the Presidential Complex
Dr. Göktuna has received his awards from Dr. Faruk Özlü who is the Minister of Science, Industry and Technology. 2016 TÜBA “International Academy Prizes, GEBİP and TEÇEP Awards” were handed to the owners under the auspices of Presidency with the ceremony held on February 1, 2017 in the Presidential Complex.
Göktuna Lab will work on a TUBITAK 3501 project which is funded by TUBITAK for three years.
• Dr. Göktuna has received The Outstanding Young Scientist Award of the year 2016 from Turkish Academy of Sciences (TUBA).
Dr. Göktuna has received The Outstanding Young Scientist Award (GEBIP) of the year 2016 from Turkish Academy of Sciences (TÜBA).
The Outstanding Young Scientist Award Programme (GEBIP)
Launched in 2001, this award programme is one of the first of its kind in the world. The objective of TÜBA-GEBIP is to foster young, outstanding scientists who are at the stage of establishing their own research programmes in Turkey after finishing their post-doctoral research activities. TÜBA supports these scientists for a period of three years and helps them set up their own research groups at a stage when they are in need for incentives. In this way TÜBA tries to contribute to develope a new generation of competent researchers from all disciplines, including social sciences and humanities, basic sciences and health sciences. The Turkish Academy of Sciences considers itself as a school to train young promising academicians.
The GEBIP programme aims to set up a kind of Young Academy of scientists under the age of 40. Aside from a grant provided for a period of three years, a member of the Academy is assigned as the mentor, and an environment of solidarity and interaction is created through joint meetings held with Academy members.
The GEBIP Programme is conducted by the GEBIP Main Committee and the GEBIP Field Committees set up by the Presidency of the Academy. Applications may be in person, by the President of the related university or the highest administrator of the related institution or by a Principal or Honorary member of the Academy.
The selection procedure among GEBIP candidates has very high standards. First, applicants prepare detailed dossiers including their international publications in refereed journals, books edited, ongoing research projects and proposed research programme, plus three letters of reference. Second, juries in four different scientific fields (field committees) evaluate and grade the applicants according to their dossiers and three referee reports. In the final stage, applicants who become GEBIP candidates according to their grade points are invited to an interview.
Zeynep Boyacıoğlu, who was senior student at Göktuna Laboratory, and İlayda Baydemir have joined to Göktuna Laboratory as Master’s Students.
• Dr. Göktuna has attended 24th Biennial Congress of the European Association for Cancer Research, EACR 2016.
Dr. Göktuna has given a lecture entitled with “Experimental Animal Models of Human Diseases & Mouse Models of Gastrointestinal Cancers” in Animal Experiments Local Ethics Committee certificate program, which is hosted by Bilkent University, on May 30, 2016.
• Dr. Göktuna has given a speech in 3rd International Molecular Immunology & Immunogenetics Congress (MIMIC-III, Antalya)
Dr. Göktuna has given a speech entitled with “IKBKE maintains a pro-inflammatory loop for intestinal tumor development” in MIMIC-III, 3rd International Molecular Immunology & Immunogenetics Congress, in Antalya, Turkey on April 29, 2016.
Dr. Göktuna has published his research article entitled “The pro-survival IKK-related kinase IKKepsilon integrates LPS and IL-17A signaling cascades to promote Wnt-dependent tumor development in the intestine.” in the Cancer Research Journal in March, 2016. This article Published in American Association for Cancer Research in March 15, 2015 with doi:
- The pro-survival IKK-related kinase IKKepsilon integrates LPS and IL-17A signaling cascades to promote Wnt-dependent tumor development in the intestine.
Dr. Goktuna has been awarded TUBITAK 2232 Career Integration Fellowship.